BioSystem Advancement announces the launch of AssayMAP MAb Titer Assay BioSystem Development, LLC., a held life technology analytics privately company, announces the launch of the AssayMAP MAb Titer Assay for measuring antibody item concentrations in bioprocess samples http://www.tadalis-reviews.com/ http://tadalis-reviews.com . Antibody titer assays certainly are a vital bottleneck in biotherapeutic process advancement. The AssayMAP MAb Titer assay uses a similar chemistry as Proteins A HPLC with a 100-fold upsurge in throughput, equivalent analytical performance and no dependence on specialized instrumentation.